Commodore Capital LP Q1 2024 Filing
Filed May 15, 2024
Portfolio Value
$1.5B
Holdings
39
Report Date
Q1 2024
Filing Type
13F-HR
All Holdings (39 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MRUSMERUS N V | 4,360,000 | $196.3T | 13128218.43% | |
| 2 | VERAVERA THERAPEUTICS INC | 3,165,000 | $136.5T | 9125776.42% | |
| 3 | NUVLNUVALENT INC | 1,487,756 | $111.7T | 7470181.82% | |
| 4 | XENEXENON PHARMACEUTICALS INC | 2,167,793 | $93.3T | 6240341.04% | |
| 5 | SYRESPYRE THERAPEUTICS INC | 1,884,084 | $71.5T | 4778597.61% | |
| 6 | ELVNENLIVEN THERAPEUTICS INC | 3,973,245 | $69.9T | 4673352.56% | |
| 7 | PCVXVAXCYTE INC | 860,000 | $58.7T | 3928258.82% | |
| 8 | BRD1EURMIND MEDICINE MINDMED INC | 5,833,333 | $54.8T | 3666586.87% | |
| 9 | NVLSEURALPINE IMMUNE SCIENCES INC | 1,375,000 | $54.5T | 3644632.15% | |
| 10 | ARVNARVINAS INC | 1,275,000 | $52.6T | 3519388.67% | |
| 11 | RYTMRHYTHM PHARMACEUTICALS INC | 1,050,000 | $45.5T | 3042253.13% | |
| 12 | COGTCOGENT BIOSCIENCES INC | 6,425,000 | $43.2T | 2887086.28% | |
| 13 | PHVSPHARVARIS N V | 1,725,000 | $39.9T | 2665670.11% | |
| 14 | TCE2CELLDEX THERAPEUTICS INC NEW | 866,468 | $36.4T | 2431693.62% | |
| 15 | NKTXNKARTA INC | 3,165,000 | $34.2T | 2287793.21% | |
| 16 | VRDNVIRIDIAN THERAPEUTICS INC | 1,934,653 | $33.9T | 2265200.17% | |
| 17 | CELCCELCUITY INC | 1,555,954 | $33.6T | 2247335.22% | |
| 18 | KURAKURA ONCOLOGY INC | 1,525,000 | $32.5T | 2175094.13% | |
| 19 | CCCCC4 THERAPEUTICS INC | 3,410,384 | $27.9T | 1863128.00% | |
| 20 | ORICORIC PHARMACEUTICALS INC | 2,000,000 | $27.5T | 1838865.87% | |
| 21 | ABVXABIVAX SA | 1,895,003 | $27.1T | 1812021.30% | |
| 22 | ISREURPERSPECTIVE THERAPEUTICS INC | 21,052,631 | $25.1T | 1675215.57% | |
| 23 | IMVTIMMUNOVANT INC | 750,990 | $24.3T | 1622514.07% | |
| 24 | KYTXKYVERNA THERAPEUTICS INC | 912,189 | $22.7T | 1515143.56% | |
| 25 | ENGNENGENE HOLDINGS INC | 1,250,000 | $21.2T | 1416762.57% | |
| 26 | APGEAPOGEE THERAPEUTICS INC | 290,000 | $19.3T | 1288576.90% | |
| 27 | CABACABALETTA BIO INC | 1,100,000 | $18.8T | 1254842.07% | |
| 28 | AUTLAUTOLUS THERAPEUTICS PLC | 2,300,000 | $14.7T | 981218.83% | |
| 29 | THRDTHIRD HARMONIC BIO INC | 1,250,000 | $11.8T | 789040.63% | |
| 30 | NGNENEUROGENE INC | 200,000 | $10.2T | 680714.71% | |
| 31 | AVU0ADVERUM BIOTECHNOLOGIES INC | 657,333 | $9.3T | 621515.87% | |
| 32 | VTGNVISTAGEN THERAPEUTICS INC | 1,575,000 | $8.3T | 556073.04% | |
| 33 | SNDXSYNDAX PHARMACEUTICALS INC | 318,851 | $7.6T | 507436.98% | |
| 34 | SLNOSOLENO THERAPEUTICS INC | 169,533 | $7.3T | 485193.92% | |
| 35 | HLXCHELIX ACQUISITION CORP II | 500,000 | $5.2T | 347712.82% | |
| 36 | MGNXMACROGENICS INC | 295,020 | $4.3T | 290386.61% | |
| 37 | TORCEURADICET BIO INC | 1,374,320 | $3.2T | 215959.88% | |
| 38 | SABSSAB BIOTHERAPEUTICS INC | 183,174 | $831.6B | 55607.97% | |
| 39 | —DBV TECHNOLOGIES S A | 92,687 | $69.4B | 4642.77% |